Skip to main content
Log in

Association of kynurenine-3-monooxygenase gene with schizophrenia

  • Human Genetics
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

Neurotoxic products produced during tryptophan metabolism via the kynurenine pathway could be involved in schizophrenia pathogenesis. It has been shown that kynurenine-3-monooxygenase (KMO) is indirectly involved in these products’ formation. KMO polymorphic loci rs2275163 (C/T) and rs1053230 (A/G) were examined in 187 schizophrenia patients and 229 healthy subjects. A genetic combination of allele T and genotype GG was observed more often in a patient group compared with healthy controls (p = 0.003, OR 2.0 (95% CI 1.2–2.9)). In the latter group, this combination was associated with schizophrenia endophenotype (p = 0.04), which manifested in a higher expression of schizotypal personality traits assessed using the MMPI test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Erhardt, S., Schwieler, L., Nilsson, L., et al., The kynurenic acid hypothesis of schizophrenia, Physiol. Behav., 2007, vol. 92, nos. 1–2, pp. 203–209.

    Article  CAS  PubMed  Google Scholar 

  2. Muller, N. and Schwarz, M., Schizophrenia as an inflammation-mediated disbalance of glutamatergic neurotransmission, Neurotox. Res., 2006, vol. 10, no. 2, pp. 131–148.

    Article  CAS  PubMed  Google Scholar 

  3. Schwarcz, R., Rassoulpour, A., Wu, H.Q., et al., Increased cortical kynurenate content in schizophrenia, Biol. Psychiatry, 2001, vol. 50, no. 7, pp. 521–530.

    Article  CAS  PubMed  Google Scholar 

  4. Wonodi, I. and Schwarcz, R., Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia, Schizophr. Bull., 2010, vol. 36, no. 2, pp. 211–218.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Sathyasaikumar, K.V., Stachowski, E.K., Wonodi, I., et al., Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia, Schizophr. Bull., 2011, vol. 37, no. 6, pp. 1147–1156.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Hamshere, M.L., Bennett, P., Williams, N., et al., Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to disc1, and suggestive evidence at 22q11 and 19p13, Arch. Gen. Psychiatry, 2005, vol. 62, no. 10, pp. 1081–1088.

    Article  CAS  PubMed  Google Scholar 

  7. Aoyama, N., Takahashi, N., Saito, S., et al., Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population, Genes Brain Behav., 2006, vol. 5, no. 4, pp. 364–368.

    Article  CAS  PubMed  Google Scholar 

  8. Holtze, M., Saetre, P., Erhardt, S., et al., Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: an association study, Schizophr. Res., 2011, vol. 127, nos. 1–3, pp. 270–272.

    Article  PubMed  Google Scholar 

  9. Holtze, M., Saetre, P., Engberg, G., et al., Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls, J. Psychiatry Neurosci., 2012, vol. 37, vol. 1, pp. 53–57.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Wonodi, I., Stine, O.C., Sathyasaikumar, K.V., et al., Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes, Arch. Gen. Psychiatry, 2011, vol. 68, no. 7, pp. 665–764.

    Article  CAS  PubMed  Google Scholar 

  11. Keshavan, M., Montrose, D.M., Rajarethinam, R., et al., Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments, Schizophr. Res., 2008, vol. 103, nos. 1–3, pp. 114–120.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Lien, Y.J., Tsuang, H.C., Chiang, A., et al., The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia, Am. J. Med. Genet., Part B, 2010, vol. 153B, pp. 1–9.

    Google Scholar 

  13. Tarbox, S.I., Almasy, L., Gur, R.E., et al., The nature of schizotypy among multigenerational multiplex schizophrenia families, J. Abnorm. Psychol., 2012, vol. 121, no. 2, pp. 396–406.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Lavebratt, C., Olsson, S., Backlund, L., The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression, Mol. Psychiatry, 2013. doi 10.1038/mp.2013.11

    Google Scholar 

  15. Craddock, N., O’Donovan, M.C., Owen, M.J., Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or “schizoaffective”) psychoses, Schizophr. Bull., 2009, vol. 35, no. 3, pp. 482–490.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. E. Golimbet.

Additional information

Original Russian Text © V.E. Golimbet, T.V. Lezheiko, M.V. Alfimova, L.I. Abramova, N.V. Kondrat’ev, 2014, published in Genetika, 2014, Vol. 50, No. 6, pp. 724–728.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Golimbet, V.E., Lezheiko, T.V., Alfimova, M.V. et al. Association of kynurenine-3-monooxygenase gene with schizophrenia. Russ J Genet 50, 634–637 (2014). https://doi.org/10.1134/S1022795414060039

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795414060039

Keywords

Navigation